Nicotine-induced conditioned place preference in rats: Sex differences and the role of mGluR5 receptors

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 374-382

  Yararbas, Gorkem ^a   Keser, Aysegul ^a   Kanit, Lutfiye ^a   Pogun, Sakire ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acetylcholine; Conditioned place preference; mGluR5; MPEP; Nicotine; Sex differences

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; METABOTROPIC RECEPTOR 5; NICOTINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; FEMALE; INHIBITION KINETICS; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE;

ANIMALS; AUTOMATION; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MALE; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; SPACE PERCEPTION;

EID: 72049099358     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.10.001     Document Type: Article

References (74)

1. Bardo M.T., and Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl) 153 1 (2000) 31-43
2. Bardo M.T., Rowlett J.K., et al. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci. Biobehav. Rev. 19 1 (1995) 39-51
3. Belluzzi J.D., Lee A.G., et al. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) 174 3 (2004) 389-395
4. Berrendero F., Mendizabal V., et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 25 5 (2005) 1103-1112
5. Bespalov A.Y., Dravolina O.A., et al. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology 49 Suppl. 1 (2005) 167-178
6. Bevins R.A., and Palmatier M.I. Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect. Behav. Brain Res. 143 1 (2003) 65-74
7. Brielmaier J.M., McDonald C.G., et al. Nicotine place preference in a biased conditioned place preference design. Pharmacol. Biochem. Behav. 89 1 (2008) 94-100
8. Calcagnetti D.J., and Schechter M.D. Nicotine place preference using the biased method of conditioning. Prog. Neuropsychopharmacol. Biol. Psychiatry 18 5 (1994) 925-933
9. Castane A., Soria G., et al. Attenuation of nicotine-induced rewarding effects in A2A knockout mice. Neuropharmacology 51 3 (2006) 631-640
10. Chen H.H., Yang Y.K., et al. Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice. Chin. J. Physiol. 46 4 (2003) 169-174
11. Chiamulera C., Epping-Jordan M.P., et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4 9 (2001) 873-874
12. Clarke P.B., and Fibiger H.C. Apparent absence of nicotine-induced conditioned place preference in rats. Psychopharmacology (Berl) 92 1 (1987) 84-88
13. Dewey S.L., Brodie J.D., et al. A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31 1 (1999) 76-86
14. Dwoskin L.P., Rauhut A.S., et al. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 12 3-4 (2006) 178-207
15. Forget B., Barthelemy S., et al. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology (Berl) 189 1 (2006) 59-69
16. Forget B., Hamon M., et al. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 181 4 (2005) 722-734
17. Fudala P.J., and Iwamoto E.T. Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav. 25 5 (1986) 1041-1049
18. Fudala P.J., Teoh K.W., et al. Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol. Biochem. Behav. 22 2 (1985) 237-241
19. Goktalay G., Cavun S., et al. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur. J. Pharmacol. 530 1-2 (2006) 95-102
20. Grabus S.D., Martin B.R., et al. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology (Berl) 184 3-4 (2006) 456-463
21. Horan B., Smith M., et al. (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse 26 1 (1997) 93-94
22. Isiegas C., Mague S.D., et al. Sex differences in response to nicotine in C57Bl/6:129SvEv mice. Nicotine Tob. Res. 11 7 (2009) 851-858
23. Janhunen S., Linnervuo A., et al. Effects of nicotine and epibatidine on locomotor activity and conditioned place preference in rats. Pharmacol. Biochem. Behav. 82 4 (2005) 758-765
24. Jorenby D.E., Steinpreis R.E., et al. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology (Berl) 101 4 (1990) 533-538
25. Kashkin V.A., and De Witte P. Nicotine increases microdialysate brain amino acid concentrations and induces conditioned place preference. Eur. Neuropsychopharmacol. 15 6 (2005) 625-632
26. Kawamura T., Ichitani Y., et al. Rewarding property of nicotine and methamphetamine tested by conditioned place preference in rats: effect of chronic nicotine pretreatment. Shinrigaku Kenkyu 76 1 (2005) 57-62
27. Kenny P.J., Gasparini F., et al. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J. Pharmacol. Exp. Ther. 306 3 (2003) 1068-1076
28. Kenny P.J., Paterson N.E., et al. Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann. N. Y. Acad. Sci. 1003 (2003) 415-418
29. Kim H.S., Kim K.S., et al. Ginseng total saponin inhibits nicotine-induced hyperactivity and conditioned place preference in mice. J. Ethnopharmacol. 66 1 (1999) 83-90
30. Kota D., Martin B.R., et al. Age-dependent differences in nicotine reward and withdrawal in female mice. Psychopharmacology (Berl) 198 2 (2008) 201-210
31. Kota D., Martin B.R., et al. Nicotine dependence and reward differ between adolescent and adult male mice. J. Pharmacol. Exp. Ther. 322 1 (2007) 399-407
32. Le Foll B., and Goldberg S.R. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15 13 (2004) 2139-2143
33. Le Foll B., and Goldberg S.R. Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Trends Pharmacol. Sci. 26 6 (2005) 287-293
34. Le Foll B., and Goldberg S.R. Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology (Berl) 178 4 (2005) 481-492
35. Le Foll B., and Goldberg S.R. Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology (Berl) 184 3-4 (2006) 367-381
36. Le Foll B., Sokoloff P., et al. Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30 4 (2005) 720-730
37. Le Foll B., Wertheim C.E., et al. Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neurosci. Lett. 443 3 (2008) 236-240
38. Liechti M.E., and Markou A. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Eur. J. Pharmacol. 554 2-3 (2007) 164-174
39. Liu Y., Le Foll B., et al. Conditioned place preference induced by licit drugs: establishment, extinction, and reinstatement. ScientificWorldJournal 8 (2008) 1228-1245
40. Markou A. Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?. Biol. Psychiatry 61 1 (2007) 17-22
41. Martin J.L., and Itzhak Y. 7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion. Neuroreport 11 5 (2000) 947-949
42. McGeehan A.J., and Olive M.F. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47 3 (2003) 240-242
43. Meehan S.M., and Schechter M.D. LSD produces conditioned place preference in male but not female fawn hooded rats. Pharmacol. Biochem. Behav. 59 1 (1998) 105-108
44. Micheli F., Bonanomi G., et al. 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists. J. Med. Chem. 50 21 (2007) 5076-5089
45. Murray J.E., and Bevins R.A. Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus. Eur. J. Pharmacol. 561 1-3 (2007) 91-104
46. Nazarian A., Russo S.J., et al. The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats. Brain Res. Bull. 63 4 (2004) 295-299
47. O'Dell L.E., and Khroyan T.V. Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans?. Pharmacol. Biochem. Behav. 91 4 (2009) 481-488
48. Olive M.F., McGeehan A.J., et al. The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol. Pharmacol. 67 2 (2005) 349-355
49. Pak A.C., Ashby Jr. C.R., et al. The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int. J. Neuropsychopharmacol. 9 5 (2006) 585-602
50. Palmatier M.I., Liu X., et al. Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine. Neuropsychopharmacology 33 9 (2008) 2139-2147
51. Papp M., Gruca P., et al. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Neuropsychopharmacology 27 5 (2002) 727-743
52. Paterson N.E., Semenova S., et al. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) 167 3 (2003) 257-264
53. Philibin S.D., Vann R.E., et al. Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol. Biochem. Behav. 80 1 (2005) 87-92
54. Picciotto M.R. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci. 24 9 (2003) 493-499
55. Pogun S., and Yararbas G. Sex differences in nicotine action. Handb Exp. Pharmacol. 192 (2009) 261-291
56. Quarta D., Naylor C.G., et al. Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine. Neuropharmacology 53 3 (2007) 421-430
57. Rauhut A.S., Zentner I.J., et al. Wistar Kyoto and Wistar rats differ in the affective and locomotor effects of nicotine. Physiol. Behav. 93 1-2 (2008) 177-188
58. Risinger F.O., and Oakes R.A. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol. Biochem. Behav. 51 2-3 (1995) 457-461
59. Russo S.J., Festa E.D., et al. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 120 2 (2003) 523-533
60. Russo S.J., Jenab S., et al. Sex differences in the conditioned rewarding effects of cocaine. Brain Res. 970 1-2 (2003) 214-220
61. Sahraei H., Aliabadi A.A., et al. Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice. Eur. J. Pharmacol. 560 1 (2007) 42-48
62. Sahraei H., Falahi M., et al. The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. Eur. J. Pharmacol. 503 1-3 (2004) 81-87
63. Scherma M., Panlilio L.V., et al. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J. Pharmacol. Exp. Ther. 327 2 (2008) 482-490
64. Shoaib M., Baumann M.H., et al. Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology (Berl) 131 3 (1997) 296-306
65. Shoaib M., Stolerman I.P., et al. Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl) 113 3-4 (1994) 445-452
66. Spina L., Fenu S., et al. Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology (Berl) 184 3-4 (2006) 447-455
67. Torrella T.A., Badanich K.A., et al. Developmental differences in nicotine place conditioning. Ann. N. Y. Acad. Sci. 1021 (2004) 399-403
68. Torres O.V., Natividad L.A., et al. Female rats display dose-dependent differences to the rewarding and aversive effects of nicotine in an age-, hormone-, and sex-dependent manner. Psychopharmacology (Berl) (2009)
69. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 6 (1998) 613-672
70. Vastola B.J., Douglas L.A., et al. Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol. Behav. 77 1 (2002) 107-114
71. Walters C.L., Brown S., et al. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 184 3-4 (2006) 339-344
72. Wilkinson J.L., and Bevins R.A. Intravenous nicotine conditions a place preference in rats using an unbiased design. Pharmacol. Biochem. Behav. 88 3 (2008) 256-264
73. Zarrindast M.R., Faraji N., et al. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 74 2 (2003) 363-369
74. Zhu H., Lee M., et al. Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice. Hum. Mol. Genet. 16 7 (2007) 820-836